Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
株式のランク #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
株価
$115.67
時価総額
$285.98B
変化(1日)
1.30%
変化(1年)
25.31%
US
取引 Merck & Co., Inc. (MRK)

カテゴリー

Merck & Co., Inc.(MRK)の利益
Dec 2025 時点の利益 TTM: $21.07B
Merck & Co., Inc. の最新の財務報告によると、同社の現在の利益は $21.07B です。2024 年には $19.94B の利益を上げ、これは 2023 年の利益 $1.89B と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Merck & Co., Inc. の利益の推移(2000 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $21.07B 0.00%
2025 $21.07B 5.67%
2024 $19.94B 955.37%
2023 $1.89B -88.51%
2022 $16.44B 18.48%
2021 $13.88B 136.72%
2020 $5.86B -18.24%
2019 $7.17B -17.58%
2018 $8.70B 33.43%
2017 $6.52B 39.97%
2016 $4.66B -13.74%
2015 $5.40B -68.75%
2014 $17.28B 211.69%
2013 $5.55B -36.55%
2012 $8.74B 19.16%
2011 $7.33B 343.68%
2010 $1.65B -89.19%
2009 $15.29B 53.96%
2008 $9.93B 194.63%
2007 $3.37B -45.82%
2006 $6.22B -15.51%
2005 $7.36B -7.98%
2004 $8.00B -11.59%
2003 $9.05B -6.22%
2002 $9.65B -2.98%
2001 $9.95B 1.26%
2000 $9.82B 0.00%
同業他社の利益
企業 利益 利益の差
$25.73B 22.13%
US
$12.40B -41.13%
GB
$32.58B 54.65%
US
$6.60B -68.69%
US
$16.35B -22.38%
CH